Patrick Johnson is the President of Sydnexis Inc., a clinical-stage biopharmaceutical company focused on myopia-related eye treatments and macular.
Patrick Johnson is the President of Sydnexis Inc., a clinical-stage biopharmaceutical company focused on myopia-related eye treatments and macular degeneration. He has discussed myopia treatment on a company-related podcast. Sydnexis is based in San Diego/Del Mar, California.
Full founder directory · Investor directory · Company funding database · Fundraising library